Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | PIM1 | P11309 | 1/20 | 0.71 |
| ▸ | MMP2 | P08253 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | METAP2 | P50579 | 2/20 | 0.53 |
| ▸ | MGAM | O43451 | 1/20 | 0.53 |
| ▸ | PLAU | P00749 | 1/20 | 0.53 |
| ▸ | NCF1 | P14598 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL171491 | 1.00 | KDM4E (1.00) | KDM4EKMT2APIM1MMP2TSHR | |
| SCHEMBL27688602 | 0.98 | KDM4E (0.96) | KDM4EKMT2APIM1MMP2TSHR | |
| SCHEMBL29932233 | 0.98 | KDM4E (0.96) | KDM4EKMT2APIM1MMP2TSHR | |
| SCHEMBL28228512 | 0.98 | KDM4E (0.96) | KDM4EKMT2APIM1MMP2TSHR | |
| SCHEMBL28949889 | 0.98 | KDM4E (0.96) | KDM4EKMT2APIM1MMP2TSHR | |
| SCHEMBL11121278 | 0.95 | KDM4E (0.90) | KDM4EKMT2APIM1MMP2TSHR | |
| SCHEMBL2059128 | 0.93 | KDM4E (0.87) | KDM4EKMT2APIM1MMP2TSHR | |
| Biphenyl SCHEMBL28885084 | 0.92 | KDM4E (0.84) | KDM4EKMT2APIM1MMP2TSHR | |
| Oxyquinoline SCHEMBL31621298 | 0.90 | KDM4E (0.81) | KDM4EKMT2APIM1MMP2TSHR | |
| Iodobenzene SCHEMBL28822053 | 0.90 | KDM4E (0.81) | KDM4EKMT2APIM1MMP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | claimed |
| WO-2024243322-A9 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| WO-2024243322-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2024-11-28 | — | — | WO | claimed |
| EP-4747668-A2 | COLOR ENHANCING OPTICAL LIGHT PROPAGATORS, OPTICAL FILMS, COLOR ENHANCING FILMS, AND FILM ASSEMBLIES, ARTICLES CONTAINING THE SAME, AND METHODS FOR PREPARING THE SAME | Immunolight, Llc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4719412-A1 | 2,8-DIHYDROXYQUINOLINE GLUCURONIDE DERIVATIVES WITH ENHANCED PROPERTIES FOR USE AS ANTICANCER, ANTIVIRAL, ANTIMICROBIAL, AND OTHER THERAPEUTIC APPLICATIONS | Westol, LLC (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4655453-A2 | ENERGY CONVERTING PARTICLES AND METHODS FOR THEIR USE IN SECURITY, ANTICOUNTERFEITING, AND ANTI-TAMPERING END-USES | Immunolight, Llc. (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4590699-A1 | METHODS OF TREATMENT WITH IFN-BETA ANTIBODIES | Pfizer Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-120309640-A | Photosensitizer for inducing copper death of tumor cells under illumination and preparation method and application thereof | 大连理工大学 | 2025-07-15 | — | — | CN | disclosed |
| WO-2024243322-A9 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025019634-A2 | COLOR ENHANCING OPTICAL LIGHT PROPAGATORS, OPTICAL FILMS, COLOR ENHANCING FILMS, AND FILM ASSEMBLIES, ARTICLES CONTAINING THE SAME, AND METHODS FOR PREPARING THE SAME | IMMUNOLIGHT, LLC (US) | 2025-01-23 | — | — | WO | disclosed |
| WO-2024249983-A1 | 2,8-DIHYDROXYQUINOLINE GLUCURONIDE DERIVATIVES WITH ENHANCED PROPERTIES FOR USE AS ANTICANCER, ANTIVIRAL, ANTIMICROBIAL, AND OTHER THERAPEUTIC APPLICATIONS | WESTOL, LLC (US) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024243322-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024175759-A1 | INDOLE-3-PROPIONIC ACID AS AN IMPORTANT CONTRIBUTOR TO VIRAL INFECTION OUTCOMES AND A BIOMARKER OF VIRAL INFECTION SEVERITY | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-08-29 | — | — | WO | disclosed |
| WO-2024158807-A2 | ENERGY CONVERTING PARTICLES AND METHODS FOR THEIR USE IN SECURITY, ANTICOUNTERFEITING, AND ANTI-TAMPERING END-USES | IMMUNOLIGHT, LLC (US) | 2024-08-02 | — | — | WO | disclosed |
| WO-2024062420-A1 | METHODS OF TREATMENT WITH IFNß ANTIBODIES | PFIZER INC. (US) | 2024-03-28 | — | — | WO | disclosed |
| EP-3249707-B1 | ORGANIC COMPOUND AND LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE USING THE SAME | LG DISPLAY CO LTD (KR) | 2023-11-22 | — | — | EP | disclosed |
| EP-4021406-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | Delpor, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| WO-2022106976-A1 | STABLE PHARMACEUTICAL FORMULATIONS OF SOLUBLE FGFR3 DECOYS | PFIZER INC. (US) | 2022-05-27 | — | — | WO | disclosed |